MedVi vs Remedy Meds 2026: GLP-1 Price & Support

MedVi vs Remedy Meds 2026: GLP-1 Price & Support. MedVi vs Remedy Meds compared head to head. Pricing, medications, results, and which GLP-1 provider wins in 2026. MedVi and Remedy Meds are two of the most talked-about telehealth platforms for compounded GLP-1 weight loss medications. Both connect patients with licensed clinicians who can prescribe semaglutide or tirzepatide, shipped directly to your door. But despite the surface similarities, these are very different companies at very different stages — and those differences matter when you're choosing who to trust with your health. This comparison breaks down everything that separates MedVi from Remedy Meds: pricing, medications, clinical support, track record, and overall value. If you're deciding between the two, this is the only guide you need. Company Overview: Scale Matters MedVi has established itself as one of the dominant players in the GLP-1 telehealth space. The numbers tell the story: 500,000+ patients served and $1.6 billion in first-year sales. That kind of scale isn't just a vanity metric — it means battle-tested infrastructure, established pharmacy relationships, reliable medication supply chains, and a clinical operation that has handled hundreds of thousands of patient interactions. When you're injecting a medication weekly, you want a provider that isn't figuring things out as they go. Remedy Meds is a newer entrant that has built a loyal following through its community-driven approach and aggressive marketing. The platform reports a 94.6% success rate (members losing 5%+ body weight) and 91% member retention past 90 days — strong numbers, but from a significantly smaller patient base. Remedy Meds has carved out a niche, but it hasn't been stress-tested at anywhere near MedVi's volume. Medications Offered Both platforms offer the two major compounded GLP-1 medications: semaglutide (the active ingredient in Ozempic/Wegovy) and tirzepatide (the active ingredient in Mounjaro/Zepbound). This means the core treatment options are identical regardless of which provider you choose. Where they diverge is in how they structure those options. Remedy Meds offers a microdose plan — a half-dose, twice-weekly injection schedule designed for patients who want a gentler titration. This is a genuinely useful option for people who are sensitive to GI side effects. MedVi, on the other hand, offers a more traditional dosing protocol with clinician-directed adjustments based on patient response. Both approaches are medically sound — the best choice depends on your tolerance and your prescriber's recommendation. Pricing Comparison Neither MedVi nor Remedy Meds publishes fully transparent pricing on their homepages, which is common in this space — final costs depend on the medication, dose, and plan you select. Both operate in the $199–$299/month range for compounded GLP-1 medications with consultations and shipping included. Neither accepts health insurance, so the full cost is out of pocket. Remedy Meds accepts HSA/FSA payments, which gives patients using tax-advantaged health accounts a way to reduce the effective cost. MedVi's pricing structure emphasizes "clear pricing with no hidden fees" — what you see at checkout is what you pay, with no surprise consultation fees or lab costs added later. Clinical Support and Provider Access This is where MedVi pulls ahead significantly. MedVi offers 24/7 unlimited clinical support — you can reach a medical professional any time, day or night. When you're dealing with side effects at 2 AM or have an urgent question about your dosing, that around-the-clock access matters. The platform also includes a dedicated patient portal for progress tracking and provider check-ins, creating a structured clinical relationship rather than a transactional one. Remedy Meds offers unlimited video calls and messaging with its care team, available 7 days a week from 8 AM to 8 PM ET. That's solid coverage, but it's not 24/7. Remedy Meds compensates with monthly check-ins, live expert sessions, and access to a 10,000+ member community for peer support. If community-driven accountability is important to you, Remedy Meds delivers here. But if you prioritize clinical access and provider availability, MedVi's always-on support is hard to beat. Results and Track Record Remedy Meds reports that members lose an average of 45 lbs in 6 months on semaglutide and 50 lbs on tirzepatide. These figures align with published clinical trial data for both compounds, which consistently show 15–20% body weight reduction over 6–12 months. Remedy Meds also claims a 94.6% success rate for members losing at least 5% of body weight — a strong figure that suggests their clinical protocols and patient selection are dialed in. MedVi doesn't publish aggregate outcome statistics in the same way, but the platform's scale speaks for itself. You don't reach $1.6 billion in first-year revenue with a product that doesn't work. MedVi's patient testimonials consistently report 1–2 lbs per week of weight loss with lifestyle modifications — conservative figures that align with realistic, sustainable outcomes. The sheer volume of patients MedVi has treated gives it a data advantage that newer platforms simply can't match. Guarantees and Risk Remedy Meds offers a 365-day money-back guarantee — if you don't achieve your weight loss results within a year, you get your money back. That's an aggressive guarantee that signals confidence in their product, and it significantly reduces the financial risk of trying the platform. For patients on the fence, this guarantee alone could tip the decision toward Remedy Meds. MedVi operates on a month-to-month subscription — you can cancel anytime without penalty. While MedVi doesn't offer a year-long results guarantee, the month-to-month flexibility means you're never locked in. If the treatment isn't working after a month or two, you stop paying. Both approaches protect the consumer, but in different ways: Remedy Meds bets on long-term outcomes, while MedVi gives you exit flexibility at every billing cycle. Pharmacy and Medication Quality Both platforms source compounded GLP-1 medications from licensed U.S. compounding pharmacies. This is a critical detail — compounded medications are not FDA-approved as finished products, so the quality of the compounding pharmacy matters enormously. Remedy Meds emphasizes that its pharmacies perform batch testing on every production run. MedVi states that it works with FDA-regulated facilities and holds LegitScript certification — a third-party verification that adds an additional layer of credibility. In practice, both providers are sourcing from reputable 503B outsourcing facilities that operate under FDA oversight. The medications contain the same active compounds (semaglutide or tirzepatide) in comparable formulations. Unless one provider's pharmacy has a specific quality issue — which would typically surface in patient reviews — the medication quality is effectively equivalent between the two platforms. Community and Lifestyle Support This is Remedy Meds' strongest differentiator. The platform includes access to a 10,000+ member community , monthly live expert sessions, and curated recipes and meal plans tailored to GLP-1 treatment. For patients who thrive on accountability and peer support, this community aspect can meaningfully impact adherence and long-term success. GLP-1 medications work best when combined with dietary and behavioral changes, and having a built-in support network makes those changes easier to sustain. MedVi takes a more clinical approach — the focus is on the provider-patient relationship rather than peer community. Your interactions are with your prescribing clinician and care team, not with other patients. Some people prefer this: they want a private, professional medical relationship without the social element. Others find it isolating. Your preference here is personal, but MedVi's clinical-first approach aligns with how most traditional healthcare works. The Verdict: MedVi Wins on Trust and Scale Both MedVi and Remedy Meds are legitimate platforms offering real GLP-1 medications with clinical oversight. Remedy Meds brings genuine strengths to the table — the community features, the 365-day guarantee, and the microdose option are all meaningful advantages for the right patient. It's not a bad choice. But when you're choosing a telehealth provider for a medication you'll inject weekly for months or longer, scale and track record matter most . MedVi has served 500,000+ patients, generated $1.6 billion in its first year, offers true 24/7 clinical support, and carries LegitScript verification. That operational maturity translates to reliable medication supply, responsive support when you need it, and the peace of mind that comes from choosing a provider that has already proven itself at massive scale. For most patients, MedVi is the safer, stronger choice. PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, shipping policy, refund policy, privacy policy, terms, and research disclaimer. The site is organized around research peptide education, supplier transparency, product comparison, vendor review content, discount-code tracking, and calculator tools for reconstitution or unit conversion research planning. PeptideStack separates research-use-only peptide information from FDA-approved medication and licensed telehealth pathways. Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption. Many pages include affiliate disclosures because PeptideStack may earn a commission when visitors click external supplier or telehealth links. That commission does not change the price paid by visitors and does not mean PeptideStack manufactures, sells, distributes, compounds, or ships peptides or medications. Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling. Blog pages connect related guides, comparison articles, FDA approval status explainers, safety context, legality resources, product pages, vendor reviews, and calculator tools so visitors can keep researching without relying on a single supplier claim. Calculator pages are educational tools for laboratory planning and should be cross-checked against professional protocols, institutional requirements, and applicable laws. Legal and disclaimer pages explain the boundaries of PeptideStack content and the responsibility of visitors who evaluate third-party vendors. The rendered interface may add interactive details such as mobile navigation labels, product tabs, share buttons, related article cards, disclosure boxes, call-to-action buttons, vendor selectors, copy-code controls, email-code forms, footer navigation, and status labels. The static HTML fallback includes this context so the same page purpose is understandable before the JavaScript application finishes loading. Visitors should treat PeptideStack as a research and comparison starting point. Final supplier evaluation should include direct review of the external vendor website, current product availability, checkout terms, applicable laws, institutional requirements, and any third-party laboratory documentation available for the exact product or batch being considered. Footer resources repeat important sitewide context: PeptideStack is independent, affiliate-supported, research-focused, and not a pharmacy or manufacturer. Pages may include links to the iOS app, calculators, blog hubs, product hubs, supplier comparisons, support contact, and policy documents. This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle. Raw HTML also includes page summaries for mobile crawlers using JavaScript rendering, desktop crawlers comparing source to rendered output, accessibility tools, and no-script visitors. The fallback is replaced by the React app in normal browsers but keeps the source document aligned with the visible page topic. This fallback keeps source HTML and rendered HTML closer for crawl diagnostics and SEO audits across crawled pages, routes, reports, and recrawls.